<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(2)</volume><submitter>Rossi S</submitter><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>Hereditary spastic paraplegias (HSPs) are a group of inherited rare neurologic disorders characterized by length-dependent degeneration of the corticospinal tracts and dorsal columns, whose prominent clinical feature is represented by spastic gait. Spastic paraplegia type 4 (SPG4, SPAST-HSP) is the most common form. We present both clinical and molecular findings of a large cohort of patients, with the aim of (1) defining the clinical spectrum of SPAST-HSP in Italy; (2) describing their molecular features; and (3) assessing genotype-phenotype correlations to identify features associated with worse disability.&lt;h4>Methods&lt;/h4>A cross-sectional retrospective study with molecular and clinical data collected in an anonymized database was performed.&lt;h4>Results&lt;/</pubmed_abstract><journal>Neurology. Genetics</journal><pagination>e664</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8969300</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network.</pubmed_title><pmcid>PMC8969300</pmcid><pubmed_authors>Dotti MT</pubmed_authors><pubmed_authors>Riso V</pubmed_authors><pubmed_authors>Santorelli FM</pubmed_authors><pubmed_authors>Stefan C</pubmed_authors><pubmed_authors>Rossi S</pubmed_authors><pubmed_authors>Dal Fabbro B</pubmed_authors><pubmed_authors>Barghigiani M</pubmed_authors><pubmed_authors>Cioffi E</pubmed_authors><pubmed_authors>Romano S</pubmed_authors><pubmed_authors>Mignarri A</pubmed_authors><pubmed_authors>Tessa A</pubmed_authors><pubmed_authors>Trovato R</pubmed_authors><pubmed_authors>Cereda C</pubmed_authors><pubmed_authors>Nicita F</pubmed_authors><pubmed_authors>Travaglini L</pubmed_authors><pubmed_authors>Ulgheri L</pubmed_authors><pubmed_authors>Bertini E</pubmed_authors><pubmed_authors>Musumeci O</pubmed_authors><pubmed_authors>Bassi MT</pubmed_authors><pubmed_authors>Pegoraro E</pubmed_authors><pubmed_authors>Martinuzzi A</pubmed_authors><pubmed_authors>Silvestri G</pubmed_authors><pubmed_authors>Gioiosa V</pubmed_authors><pubmed_authors>Rumore R</pubmed_authors><pubmed_authors>Rizzo G</pubmed_authors><pubmed_authors>Scarlato M</pubmed_authors><pubmed_authors>Moroni R</pubmed_authors><pubmed_authors>Criscuolo C</pubmed_authors><pubmed_authors>Orlacchio A</pubmed_authors><pubmed_authors>Orsi L</pubmed_authors><pubmed_authors>Vazza G</pubmed_authors><pubmed_authors>Sampaolo S</pubmed_authors><pubmed_authors>Casali C</pubmed_authors><pubmed_authors>Battini R</pubmed_authors><pubmed_authors>Petrucci A</pubmed_authors><pubmed_authors>Straccia G</pubmed_authors><pubmed_authors>Diamanti L</pubmed_authors><pubmed_authors>Orologio I</pubmed_authors><pubmed_authors>Liguori R</pubmed_authors><pubmed_authors>Rubegni A</pubmed_authors><pubmed_authors>Dato C</pubmed_authors><pubmed_authors>Massa R</pubmed_authors><pubmed_authors>Seri M</pubmed_authors><pubmed_authors>Di Muzio A</pubmed_authors><pubmed_authors>Plumari M</pubmed_authors><pubmed_authors>D'Angelo MG</pubmed_authors><pubmed_authors>Filla A</pubmed_authors><pubmed_authors>Melone MAB</pubmed_authors><pubmed_authors>Ricca I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network.</name><description>&lt;h4>Background and objectives&lt;/h4>Hereditary spastic paraplegias (HSPs) are a group of inherited rare neurologic disorders characterized by length-dependent degeneration of the corticospinal tracts and dorsal columns, whose prominent clinical feature is represented by spastic gait. Spastic paraplegia type 4 (SPG4, SPAST-HSP) is the most common form. We present both clinical and molecular findings of a large cohort of patients, with the aim of (1) defining the clinical spectrum of SPAST-HSP in Italy; (2) describing their molecular features; and (3) assessing genotype-phenotype correlations to identify features associated with worse disability.&lt;h4>Methods&lt;/h4>A cross-sectional retrospective study with molecular and clinical data collected in an anonymized database was performed.&lt;h4>Results&lt;/</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-22T10:52:45.079Z</modification><creation>2024-11-19T21:19:15.146Z</creation></dates><accession>S-EPMC8969300</accession><cross_references><pubmed>35372684</pubmed><doi>10.1212/NXG.0000000000000664</doi></cross_references></HashMap>